What can a patient with a history of miscarriage learn from the findings of a dilation and curettage (D&C) procedure regarding the cause of their miscarriage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What Findings from D&C Can Reveal About Miscarriage Causes

The primary finding from D&C tissue analysis after miscarriage is chromosomal abnormalities, which are identified in approximately 71.6% of cases and represent the most common identifiable cause of pregnancy loss. 1

Key Diagnostic Information from D&C Tissue Analysis

Chromosomal Abnormalities (Most Common Finding)

  • Karyotyping of tissue obtained during D&C identifies chromosomal abnormalities in approximately 71.6% of miscarriages, with this rate being higher than classic estimates but consistent with recent studies in infertile populations 1

  • Trisomy is the most frequent chromosomal abnormality detected, with rates increasing in older patients (though not always reaching statistical significance) 1

  • Monosomy X is more commonly identified in younger patients (under age 38), representing a distinct pattern of chromosomal loss 1

  • The likelihood of finding chromosomal abnormalities increases significantly with maternal age, with patients having abnormal cytogenetics being older on average (38.6 years versus 36.3 years) 1

What D&C Findings Cannot Determine

  • D&C tissue analysis has significant limitations - many practitioners do not uniformly recommend D&C for all patients at the time of miscarriage diagnosis, which means not all patients receive this potentially informative testing 1

  • The absence of chorionic villi on pathology after D&C may indicate ectopic pregnancy rather than intrauterine pregnancy loss, requiring different diagnostic and management approaches 2

Clinical Algorithm for Obtaining Diagnostic Information

When to Pursue Tissue Analysis

  • Consider chromosomal analysis particularly in patients with:
    • Advanced maternal age (≥35 years), as chromosomal abnormalities are more likely 1
    • Recurrent pregnancy losses (two or more), as this may guide future management 3
    • Desire for definitive cause determination to inform future pregnancy planning 1

Important Counseling Points

  • Inform patients that finding a chromosomal abnormality provides reassurance that the miscarriage was likely due to a random genetic event rather than a preventable maternal factor 1

  • Explain that approximately 28-29% of miscarriages will not reveal a chromosomal cause, meaning other factors (anatomic, hormonal, immunologic, or unexplained) may be responsible 1

  • Discuss that the information obtained may be particularly valuable for older patients, as the classic association between advancing age and chromosomal abnormalities is consistently affirmed 1

Critical Limitations and Caveats

  • The decision to perform D&C versus expectant or medical management should not be based solely on desire for tissue analysis, as D&C carries risks including increased rates of spontaneous preterm birth in future pregnancies (adjusted OR 1.64 for miscarriage managed by D&C) 3

  • D&C may predispose to postpartum hemorrhage in subsequent pregnancies, with significantly higher incidence than previously reported averages 4

  • Tissue analysis requires adequate sample collection - if chorionic villi are not obtained, the procedure may not yield diagnostic information and could indicate ectopic pregnancy 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.